首页> 外文期刊>British Journal of Clinical Pharmacology >A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark.
【24h】

A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark.

机译:丹麦基于母亲的阿莫西林使用和妊娠结局的人群研究。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: Amoxicillin is a widely used penicillin, but data on its safety in pregnancy are limited. We examined the association between amoxicillin exposure during pregnancy and birth weight, preterm delivery, congenital malformations, perinatal death, and spontaneous abortion. METHODS: We identified all primiparous women with a live birth, or a stillbirth after the 28th gestational week, from 1 January 1991-31 December 2000 in the County of North Jutland, Denmark. Data on prescriptions for amoxicillin and outcome were obtained from population-based registries. Using a follow-up and a case-control design, we compared pregnancy outcomes between women who had been prescribed amoxicillin during pregnancy and those who had not, adjusting for available potentially confounding factors. RESULTS: We identified 401 primiparous women who redeemed a prescription for amoxicillin during their pregnancy. The control group consisted of 10 237 primiparous women who did not redeem any prescriptions from 3 months before pregnancy until the end of pregnancy. The adjusted mean birth weight of children born to amoxicillin-exposed mothers was 57 g [95% confidence interval (CI) 9, 105] higher than that of children born to controls. Odds ratios among amoxicillin-exposed relative to controls were: low birth weight 0.63 (95% CI 0.26, 1.53), preterm delivery 0.77 (95% CI 0.49, 1.21), congenital malformation 1.16 (95% CI 0.54, 2.50), and spontaneous abortion 0.89 (95% CI 0.66, 1.18). We did not observe any cases of perinatal death in the amoxicillin-exposed women. CONCLUSIONS: We did not find any increased risk of adverse pregnancy outcome associated with amoxicillin exposure during pregnancy, but additional studies are warranted.
机译:目的:阿莫西林是一种广泛使用的青霉素,但其在妊娠中的安全性数据有限。我们检查了孕期阿莫西林暴露与出生体重,早产,先天性畸形,围产期死亡和自然流产之间的关系。方法:我们鉴定了1991年1月1日至2000年12月31日在丹麦北日德兰郡第28个孕周后有活产或死产的所有初产妇女。阿莫西林处方和结果的数据是从基于人口的登记处获得的。通过随访和病例对照设计,我们比较了在怀孕期间开过阿莫西林处方的妇女和没有怀孕的妇女之间的妊娠结局,并调整了可能的混杂因素。结果:我们确定了401名初产妇女在怀孕期间赎回了阿莫西林的处方。对照组由10 237名初产妇女组成,这些妇女从怀孕前三个月到怀孕结束前没有兑换任何处方。阿莫西林接触的母亲所生孩子的调整后平均出生体重比对照组生的孩子高57 g [95%置信区间(CI)9、105]。暴露于阿莫西林相对于对照组的几率是:低出生体重0.63(95%CI 0.26,1.53),早产0.77(95%CI 0.49,1.21),先天性畸形1.16(95%CI 0.54,2.50)和自发性流产0.89(95%CI 0.66,1.18)。我们没有观察到阿莫西林暴露妇女围产期死亡的任何情况。结论:我们没有发现妊娠期间与阿莫西林暴露有关的不良妊娠结局风险增加,但值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号